Targeting the core components of the Hsp90 chaperoning machine

瞄准Hsp90陪伴机核心部件

基本信息

  • 批准号:
    8651503
  • 负责人:
  • 金额:
    $ 25.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-15 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Molecular chaperones are key players in the maintenance of a healthy proteome and in homeostasis of the cell. Dysregulation in the function of molecular chaperones leads to many metabolic, oncological, neurodegenerative, and cardiovascular diseases. The Hsp90 chaperoning machine, in particular, involves a number of chaperones and co-chaperones that, through a complex network of interactions, ensure the folding and the functionality of many key regulatory proteins. Current information suggests that targeting this machine may have a significant and combinatorial impact on dysfunctional circuitries that underlie human diseases such as cancer and neurodegenerative diseases. Novel small-molecule compounds that target the Hsp90 machine in a selective manner are needed. They will provide tools and molecular probes to further dissect the biology of this machine to better understand its role in disease etiology and progression, and to facilitate the subsequent development of therapeutics against relevant targets. This application aims to develop a high- throughput assay based on progesterone and glucocorticoid receptors, which are physiological clients of Hsp90, and the core components of the Hsp90 chaperoning machine (Hsp90, Hsp70, Hsp40, Hop, and p23). This assay would significantly enhance the discovery of chemical probes that would affect the functional core of the Hsp90 machine. It would also provide the long sought-after screening tool for specific inhibitors of Hsp90 alpha and beta isoforms and facilitate the identification of molecular targets of active compounds.
描述(由申请人提供):分子伴侣是维持健康蛋白质组和细胞稳态的关键参与者。分子伴侣的功能失调导致许多代谢、肿瘤、神经退行性和心血管疾病。特别是Hsp90分子伴侣机制,涉及许多分子伴侣和辅助分子伴侣,通过复杂的相互作用网络,确保许多关键调控蛋白的折叠和功能。目前的信息表明,靶向这台机器可能对导致癌症和神经退行性疾病等人类疾病的功能障碍电路产生重大的组合影响。需要以选择性方式靶向Hsp90机器的新型小分子化合物。他们将提供工具和分子探针,以进一步剖析这种机器的生物学,以更好地了解其在疾病病因和进展中的作用,并促进随后针对相关靶点的治疗方法的开发。本申请旨在开发一种基于孕酮和糖皮质激素受体的高通量测定法,孕酮和糖皮质激素受体是Hsp90的生理客户,以及Hsp90伴侣机器的核心组分(Hsp90、Hsp70、Hsp40、Hop和p23)。这种测定将显著增强影响Hsp90机器功能核心的化学探针的发现。它还将为Hsp90 α和β亚型的特异性抑制剂提供长期寻求的筛选工具,并促进 活性化合物分子靶点的鉴定。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Progesterone receptor chaperone complex-based high-throughput screening assay: identification of capsaicin as an inhibitor of the Hsp90 machine.
  • DOI:
    10.1177/1087057114549147
  • 发表时间:
    2015-02
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Patwardhan CA;Alfa E;Lu S;Chadli A
  • 通讯作者:
    Chadli A
Bioactive metabolites from Chaetomium aureum: structure elucidation and inhibition of the Hsp90 machine chaperoning activity.
  • DOI:
    10.1016/j.bmc.2014.11.021
  • 发表时间:
    2015-01-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Kabbaj FZ;Lu S;Faouzi Mel A;Meddah B;Proksch P;Cherrah Y;Altenbach HJ;Aly AH;Chadli A;Debbab A
  • 通讯作者:
    Debbab A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ahmed Chadli其他文献

Ahmed Chadli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ahmed Chadli', 18)}}的其他基金

A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
通过抑制 Hsp90 和降低免疫耐受来根除乳腺癌的新治疗策略
  • 批准号:
    10591405
  • 财政年份:
    2021
  • 资助金额:
    $ 25.58万
  • 项目类别:
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
通过抑制 Hsp90 和降低免疫耐受来根除乳腺癌的新治疗策略
  • 批准号:
    10320460
  • 财政年份:
    2021
  • 资助金额:
    $ 25.58万
  • 项目类别:
Targeting the core components of the Hsp90 chaperoning machine
瞄准Hsp90陪伴机核心部件
  • 批准号:
    8509718
  • 财政年份:
    2012
  • 资助金额:
    $ 25.58万
  • 项目类别:
Targeting the core components of the Hsp90 chaperoning machine
瞄准Hsp90陪伴机核心部件
  • 批准号:
    8344548
  • 财政年份:
    2012
  • 资助金额:
    $ 25.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了